Efficacy and safety of nebivolol in Korean patients with hypertension by age and sex: a subanalysis from the BENEFIT-KOREA study

BACKGROUND: BENEFIT-KOREA (BEnefits after 24 weeks of NEbivolol administration For essential hypertensIon patients wiTh various comorbidities and treatment environments in Korea) study, an observational study in South Korea, demonstrated the efficacy and safety of nebivolol in Asian patients with es...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Kyoung Im, Jeon, Dong Woon, Ahn, Hyo Seung, Jin, Dong Kyu, Lee, Hyun Sang, Lee, Jong-Young, Lim, Hong-Seok, Manolis, Athanasios J., Rha, Seung-Woon, Park, Sang Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958700/
https://www.ncbi.nlm.nih.gov/pubmed/33722290
http://dx.doi.org/10.1186/s40885-021-00165-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958700/
https://www.ncbi.nlm.nih.gov/pubmed/33722290
http://dx.doi.org/10.1186/s40885-021-00165-3

Ejemplares similares